ArticleEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2018

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation.

Adam J R Gadd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.